IAN READ

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1525356
                    [Title] => Pfizer, Allergan $160B deal forms world's largest drugmaker
                    [Summary] => 
Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.

                    [DatePublished] => 2015-11-23 07:47:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 636390
                    [Title] => Pfizer CEO Jeffrey Kindler steps down unexpectedly
                    [Summary] => 
Jeffrey B. Kindler, the CEO of the world's biggest drugmaker, stepped down Sunday unexpectedly — after less than five years heading Pfizer Inc., a period in which he reorganized most of the company's operations and made an imprint on the industry.
                    [DatePublished] => 2010-12-06 10:49:11
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest

Pfizer, Allergan $160B deal forms world's largest drugmaker

November 23, 2015 - 7:47am

Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.

Business

Pfizer CEO Jeffrey Kindler steps down unexpectedly

December 6, 2010 - 10:49am

Jeffrey B. Kindler, the CEO of the world's biggest drugmaker, stepped down Sunday unexpectedly — after less than five years heading Pfizer Inc., a period in which he reorganized most of the company's operations...